Evolus, Inc.
EOLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001570562
In the last 90 days, Evolus, Inc. insiders filed 0 open-market purchases and 1 sale; 158 institutions reported holding it in 13F filings for Q2 2026, worth $335.1M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Evolus, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- −7 vs. Q3 2021
- Shares held
- 20.6M
- +2.99M (+17.0%) vs. Q3 2021
- Total value
- $133.1M
- −$1.42M (−1.1%) vs. Q3 2021
- New holders
- 18
- 36 more added
- Sold out
- 25
- 29 more reduced
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EOLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 158 | $335.1M |
| Q1 2026 | 147 | $188.3M |
| Q4 2025 | 169 | $327.3M |
| Q3 2025 | 160 | $334.4M |
| Q2 2025 | 172 | $538.8M |
| Q1 2025 | 179 | $652.9M |
| Q4 2024 | 164 | $573.1M |
| Q3 2024 | 165 | $814.5M |
| Q2 2024 | 156 | $557.1M |
| Q1 2024 | 164 | $691.0M |
| Q4 2023 | 151 | $479.6M |
| Q3 2023 | 137 | $378.8M |
| Q2 2023 | 135 | $271.1M |
| Q1 2023 | 126 | $288.7M |
| Q4 2022 | 120 | $219.8M |
| Q3 2022 | 130 | $205.7M |
| Q2 2022 | 123 | $294.2M |
| Q1 2022 | 118 | $266.3M |
| Q4 2021 | 104 | $133.1M |
| Q3 2021 | 113 | $134.9M |
| Q2 2021 | 115 | $205.3M |
| Q1 2021 | 96 | $111.8M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Evolus, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 1,863,096 | $12.1M | 5.57% | +1,563,096+521.0% | Added |
| BlackRock Inc. | 2,226,921 | $14.5M | 0.00% | +54,531+2.5% | Added |
| Schroder Investment Management Group | 2,317,281 | $15.1M | 0.02% | +636,109+37.8% | Added |
| First Manhattan Co | 3,334,916 | $21.7M | 0.07% | +1,305,009+64.3% | Added |
| Maven Securities LTD | 0 | $0 | 0.00% | −560,481−100.0% | Sold out |
| HealthInvest Partners AB | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −255,537−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −186,044−100.0% | Sold out |
| Castle Hook Partners LP | 0 | $0 | 0.00% | −123,195−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −118,492−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −94,520−100.0% | Sold out |
| Summit Global Investments | 0 | $0 | 0.00% | −59,100−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −45,341−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −44,207−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −41,625−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −18,749−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −16,346−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −14,039−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −10,340−100.0% | Sold out |
| First Quadrant L P | 0 | $0 | 0.00% | −5,346−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −4,123−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,276−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −2,791−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −1,574−100.0% | Sold out |
| FinTrust Capital Advisors, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| BerganKDV Wealth Management, LLC | 0 | $0 | 0.00% | −275−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −67−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Arkadios Wealth Advisors | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |
| Sonora Investment Management, LLC | – | – | – | – | Not filed |